The Genetic Puzzle of Familial Atrial Fibrillation

The Genetic Puzzle of Familial Atrial Fibrillation
Written by: biancaafiponline-org

Atrial fibrillation (AF) is the most common progressive tachyarrhythmia. In Europe, AF is expected to reach a prevalence of 18 million by 2060. This estimate will increase hospitalization for AF to 4 million and 120 million outpatient visits.

Besides being an independent risk factor for mortality, AF is also associated with an increased risk of morbidities. Although there are many well-defined risk factors for developing AF, no identifiable risk factors or cardiac pathology is seen in up to 30% of the cases.

The heritability of AF has been investigated in depth since the first report of familial atrial fibrillation (FAF) in 1936. Despite the limited value of animal models, the advances in molecular genetics enabled identification of many common and rare variants related to FAF.

The importance of AF heritability originates from the high prevalence of lone AF and the lack of clear understanding of the underlying pathophysiology. A better understanding of FAF will facilitate early identification of people at high risk of developing FAF and subsequent development of more effective management options.

In the review paper of Ahmed Ragab et al, FAF epidemiological studies describing common and rare variants are reviewed. Also, their clinical implications and contributions to developing new personalized therapeutic strategies are discussed.

Want to read more? Read the paper via the frontiers website

 

Do you know someone who might be interested in this?

Related articles

genetic puzzle of familial atrial fibrillation

The Genetic Puzzle of Familial Atrial Fibrillation

The Genetic Puzzle of Familial Atrial Fibrillation
Written by: Prof. Dr. Bianca Brundel

Atrial fibrillation (AF) is the most common progressive tachyarrhythmia. In Europe, AF is expected to reach a prevalence of 18 million by 2060. This estimate will increase hospitalization for AF

Jin Li, Amsterdam UMC

DNA damage as a new biomarker for Atrial Fibrillation

DNA damage as a new biomarker for Atrial Fibrillation
Written by: Prof. Dr. Bianca Brundel , ,

Last year, AFIP published an article on the discovery made by the team of Prof. Bianca Brundel (Amsterdam UMC), that atrial fibrillation (AF) is associated with DNA damage in the

Cell-free circulating mitochondrial DNA: a potential blood-based marker for atrial fibrillation

Cell-free circulating mitochondrial DNA: a potential blood-based marker for atrial fibrillation
Written by: Prof. Dr. Bianca Brundel ,

Atrial fibrillation (AF) is the most common progressive cardiac tachyarrhythmia globally. AF is present in 3% of the total population, with a higher prevalence in the elderly, and is associated

Leave a Reply

Your email address will not be published. Required fields are marked *